Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2020-07-02 Director's Dealing
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
DGAP-DD: Bio-Gate AG deutsch
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains sections detailing transactions by a person in a management position ('Vorstand' - Executive Board Member) involving company shares. The German header 'DGAP-DD: Bio-Gate AG deutsch' and the description 'Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen' directly correspond to insider trading reports or director's dealings disclosures. This matches the definition for 'Director's Dealing' (DIRS).
2020-07-02 German
DGAP-DD: Bio-Gate AG deutsch
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information regarding transactions made by a member of the management board ('Vorstand', Marc Lloret-Grau). Section 4 details the nature of the transaction, including the exercise of stock options related to an employee participation program, the price, volume, and date. This directly corresponds to the definition of Director's Dealing (insider trades by executives). The German header 'DGAP-DD' further confirms this classification, as 'DD' stands for Directors' Dealings in this context.
2020-07-02 German
Bio-Gate AG: Bio-Gate schliet Kooperationsvertrag mit Aesculap AG fur Beschichtung von Revisionsimplantaten
M&A Activity Classification · 99% confidence The document is a press release dated June 24, 2020, announcing a cooperation agreement between Bio-Gate AG and Aesculap AG regarding the coating of revision implants. It details a business development and partnership, not a mandatory financial filing like a 10-K, an earnings release (ER), or a formal dividend notice (DIV). It is a general corporate announcement distributed via DGAP News. Since it is a news item about a significant business development (cooperation agreement) that doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director's Dealing (DIRS), the most appropriate general category for significant, non-financial regulatory news that isn't a standard report is 'Regulatory Filings' (RNS), which serves as a broad category for miscellaneous corporate news announcements distributed through official channels like DGAP.
2020-06-24 German
Bio-Gate AG: Bio-Gate schafft Voraussetzungen fur Umsatz- und Ergebnisverbesserungen 2020
Earnings Release Classification · 100% confidence The document is a press release dated June 8, 2020, detailing the financial results for the fiscal year 2019 (Umsatz 2019 bei rund 3,5 Mio. Euro, Konzernergebnis 2019 bei rund -1,0 Mio. Euro). It provides key financial highlights, business segment updates, and an outlook for 2020. This format, focusing on summarizing period results immediately after the period ends, aligns perfectly with an Earnings Release (ER). Although it mentions the full annual report is available elsewhere, this specific document is the initial announcement of the results, not the comprehensive 10-K or the full Audit Report (AR). It is too detailed for just a Report Publication Announcement (RPA) and contains specific financial figures, ruling out RPA/RNS. FY 2019
2020-06-08 German
DGAP-DD: Bio-Gate AG deutsch
Director's Dealing Classification · 100% confidence The document is titled 'DGAP-DD: Bio-Gate AG deutsch' and contains the header 'Directors’ Dealings'. It explicitly details transactions made by a person in a leadership role ('Aufsichtsrat' - Supervisory Board member) involving the company's shares ('Art: Aktie'). Specifically, it describes the 'Zeichnung von neuen Aktien im Rahmen einer Kapitalerhöhung unter Bezugsrechtsausschluss' (Subscription of new shares in the context of a capital increase excluding pre-emptive rights). This content directly aligns with the definition of Director's Dealing (insider trades) or potentially a Capital/Financing Update, but the primary focus and explicit header point to insider transactions by a director/executive. The category 'Directors' Dealing' (DIRS) is the most precise fit for reporting personal share transactions by company directors and executives, even if the transaction type is related to a capital raise.
2020-05-12 German
Bio-Gate AG: Bio-Gate AG beschliet und platziert Barkapitalerhohung aus genehmigtem Kapital
Capital/Financing Update Classification · 99% confidence The document is an 'Ad-hoc-Mitteilung' (Ad-hoc announcement) dated May 12, 2020, explicitly stating that Bio-Gate AG has decided upon and placed a cash capital increase ('Barkapitalerhöhung') from authorized capital. This action involves issuing new shares and excluding pre-emptive rights, which directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not an earnings release (ER), an interim report (IR), or a full annual report (10-K).
2020-05-12 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.